Mark A. Greenberg

5.5k total citations · 1 hit paper
54 papers, 4.4k citations indexed

About

Mark A. Greenberg is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Greenberg has authored 54 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Greenberg's work include Acute Myocardial Infarction Research (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Function and Risk Factors (6 papers). Mark A. Greenberg is often cited by papers focused on Acute Myocardial Infarction Research (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiovascular Function and Risk Factors (6 papers). Mark A. Greenberg collaborates with scholars based in United States, Canada and Belgium. Mark A. Greenberg's co-authors include Hiltrud S. Mueller, Richard Grose, Janet Strain, Mark Menegus, Michael V. Cohen, Thierry H. LeJemtel, Hugo Spindola‐Franco, Judith S. Hochman, Deborah L. Birx and Kenrad E. Nelson and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Mark A. Greenberg

53 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

1985 3.1k citations Hiltrud S. Mueller, Mark A. Greenberg et al. profile →

Peers

Countries citing papers authored by Mark A. Greenberg

Since Specialization

Citations

This map shows the geographic impact of Mark A. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Greenberg more than expected).

Fields of papers citing papers by Mark A. Greenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Greenberg. The network helps show where Mark A. Greenberg may publish in the future.

Co-authorship network of co-authors of Mark A. Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Greenberg. A scholar is included among the top collaborators of Mark A. Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Greenberg. Mark A. Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EE438 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV LRTD) in the US Birth Cohort 2023 ·Value in Health ·Alexia Kieffer, (unknown), (unknown), (unknown), Meng Su, Jason K. H. Lee, Caterina Rizzo, Mark A. Greenberg	0
2	Comparison of Index Hospitalization Costs Between Robotic CABG and Conventional CABG: Implications for Hybrid Coronary Revascularization 2015 ·Journal of Cardiothoracic and Vascular Anesthesia ·Galina Leyvi, Clyde B. Schechter, (unknown), Mark A. Greenberg, (unknown), S. Forest, (unknown), Nan Wang, (unknown), Joseph J. DeRose	21
3	Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial 2006 ·Journal of Thrombosis and Thrombolysis ·C. Michael Gibson, Cafer Zorkun, Peter Molhoek, Krzysztof Żmudka, Mark A. Greenberg, Hiltrud S. Mueller, (unknown), Hans W. Louwerenburg, Alan Niederman, (unknown), Mahesh Bikkina, (unknown), (unknown), Sabina A. Murphy, Carolyn H. McCabe	6
4	Improved speed and stability of st-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute st-segment elevation myocardial infarction 2004 ·Journal of the American College of Cardiology ·Matthew T. Roe, Cynthia L. Green, Robert P. Giugliano, C. Michael Gibson, Kenneth W. Baran, Mark A. Greenberg, Sebastian T. Palmeri, Suzanne W. Crater, (unknown), (unknown), Robert A. Harrington, Mitchell W. Krucoff	20
5	Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A Thrombolysis in Myocardial Infarction 10B substudy 2001 ·American Heart Journal ·Vankeepuram Srinivas, Christopher P. Cannon, C. Michael Gibson, Elliott M. Antman, Mark A. Greenberg, Milenko J. Tanasijevic, Sabina A. Murphy, James A. de Lemos, Seth I. Sokol, Eugene Braunwald, Hiltrud S. Mueller	10
6	Low-dose enoximone improves exercise capacity in chronic heart failure∗∗A list of the Enoximone Study Group Members and institutional affiliations is provided in the appendix. 2000 ·Journal of the American College of Cardiology ·Brian D. Lowes, Michael B. Higginbotham, (unknown), Marcus A. DeWood, Mark A. Greenberg, Peter S. Rahko, G. William Dec, Thierry H. LeJemtel, Robert L. Roden, (unknown), A. Robertson, Richard J. Gorczynski, Michael R. Bristow	37
7	Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry 2000 ·Journal of the American College of Cardiology ·James Slater, Robert Brown, (unknown), Venu Menon, Jean Boland, Jacques Col, Vladimír Džavík, Mark A. Greenberg, Mark Menegus, Cliff P. Connery, Judith S. Hochman	112
8	Successful intracoronary thrombolysis in cocaine-associated acute myocardial infarction 1997 ·Catheterization and Cardiovascular Diagnosis ·(unknown), Hugo Spindola‐Franco, Mark Menegus, Mark A. Greenberg, Mark Goldberger, Jamshid Shirani	11
9	Should All Patients Undergoing Cardiac Catheterization or Percutaneous Transluminal Coronary Angioplasty Receive Oxygen? 1994 ·CHEST Journal ·David Amar, Mark A. Greenberg, Mark Menegus, (unknown)	5
10	Potentially Misleading Bone Scan Findings in Patients With Hepatoblastoma 1993 ·Clinical Nuclear Medicine ·(unknown), Paul Babyn, (unknown), Mark A. Greenberg	13
11	Spontaneous coronary dissection treated with directional coronary atherectomy 1993 ·Catheterization and Cardiovascular Diagnosis ·Richard Charney, (unknown), Mark Menegus, Michael S. Feld, (unknown), Hugo Spindola‐Franco, Mark A. Greenberg	2
12	Early experience with the smart laser in the treatment of atherosclerotic occlusions 1991 ·American Heart Journal ·Frank J. Veith, Curtis W. Bakal, Jacob Cynamon, Sushil K. Gupta, (unknown), Mark A. Greenberg, (unknown), Kurt R. Wengerter, (unknown)	1
13	Pulmonary Malacoplakia in a Child 1990 ·Pediatric Pathology ·Roger W. Byard, Paul S. Thorner, Vern Edwards, Mark A. Greenberg	15
14	Ischemia-induced diastolic dysfunction: New observations, new questions 1989 ·Journal of the American College of Cardiology ·Mark A. Greenberg, Mark Menegus	4
15	Safe administration of mumps-measles-rubella vaccine in egg-allergic children 1988 ·The Journal of Pediatrics ·Mark A. Greenberg, Deborah L. Birx	35
16	Late systemic-allergic reactions to inhalant allergen immunotherapy 1988 ·Journal of Allergy and Clinical Immunology ·Mark A. Greenberg, Christina L. Kaufman, (unknown), (unknown), (unknown), Richard L. Summers	27
17	Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries 1987 ·Journal of the American College of Cardiology ·Mark A. Greenberg, Richard Grose, (unknown), (unknown), Janet Strain, Michael V. Cohen	98
18	Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure 1986 ·Journal of the American College of Cardiology ·Richard Grose, Janet Strain, Mark A. Greenberg, Thierry H. LeJemtel	119
19	Exercise training in patients with coronary artery disease. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·J. Scheuer, Mark A. Greenberg, Lenore R. Zohman	9
20	Hypertension detection in a hospital podiatry clinic 1974 ·Journal of the American Podiatric Medical Association ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mark A. Greenberg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact